Collegium Pharmaceutical
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell COLL and other ETFs, options, and stocks.About COLL
Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic.
CEOVikram Karnani
CEOVikram Karnani
Employees357
Employees357
HeadquartersStoughton, Massachusetts
HeadquartersStoughton, Massachusetts
Founded2002
Founded2002
Employees357
Employees357
COLL Key Statistics
Market cap1.21B
Market cap1.21B
Price-Earnings ratio36.99
Price-Earnings ratio36.99
Dividend yield—
Dividend yield—
Average volume429.26K
Average volume429.26K
High today$39.56
High today$39.56
Low today$38.18
Low today$38.18
Open price$39.23
Open price$39.23
Volume426.82K
Volume426.82K
52 Week high$42.29
52 Week high$42.29
52 Week low$23.23
52 Week low$23.23
COLL News
TipRanks 3d
Top Executive Sells Thousands of Collegium Pharmaceutical Shares!New insider activity at Collegium Pharmaceutical ( (COLL) ) has taken place on September 3, 2025. Elevate Your Investing Strategy: Take advantage of TipRanks Pr...
People also own
Based on the portfolios of people who own COLL. This list is generated using Robinhood data, and it’s not a recommendation.